Cergentis

    OverviewSuggest Edit

    Cergentis is a genomics company specializing in precision medicine. It provides services and kits based on its proprietary Targeted Locus Amplification technology to diagnostic labs, research institutes, and pharmaceutical companies.
    TypePrivate
    Founded2012
    HQUtrecht, NL
    Websitecergentis.com

    Latest Updates

    Employees (est.) (Nov 2021)38(-2%)
    Cybersecurity ratingCMore
    Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
    Banner background

    Key People/Management at Cergentis

    Joris Schuurmans

    Joris Schuurmans

    Chief Executive Officer
    Jan Dekker

    Jan Dekker

    CEO
    Jan Groen

    Jan Groen

    Chairman
    Max van Min

    Max van Min

    Chief Scientific Officer
    Marc Dijkstra

    Marc Dijkstra

    Chief Financial Officer
    Erik Splinter

    Erik Splinter

    Chief Technology Officer
    Show more

    Cergentis Office Locations

    Cergentis has an office in Utrecht
    Utrecht, NL (HQ)
    Alexander Numangebouw, Yalelaan 62
    Show all (1)

    Cergentis Financials and Metrics

    Summary Metrics

    Founding Date

    2012

    Cergentis Cybersecurity Score

    Cybersecurity ratingPremium dataset

    C

    79/100

    SecurityScorecard logo

    Cergentis Online and Social Media Presence

    Embed Graph

    Cergentis Blogs

    A method to rapidly generate lentiviral vector producer cell lines

    Transient transfection of multiple plasmids into adherent HEK293T cells is currently the standard approach to manufacture clinical-grade lentiviral vectors.1-2 However, this strategy is (1) uneconomical, (2) has lengthy schedules to source plasmid DNA and (3) presents scalability challenges. Therefo…

    Do not let unexpected genetic events go undetected and falter the commercialization of your ATMPs

    Last month, a chromosomal abnormality detected in a single patient prompted the FDA to discontinue the testing of an allogeneic CAR-T product in clinical trial.1 This news shook the biotech/pharma scene and stimulated fierce discussion surrounding the topic of genetic safety. Earlier this year, Blue…

    Cergentis introduces in-house solution for CHO clone selection

    Accelerating time to clinic by de-risking clone selection early in the cell line development process  

    Characterizing insert integrity throughout GTMP manufacturing as requested by the FDA and EMA

    To date, the number of gene therapy medicinal products (GTMP) tested in clinical trials is thriving. However, there is meagre information available regarding the exact molecular characterization - of various GTMPs under investigation - throughout the entire production chain.1-3 To mend …

    Targeted TCR editing empowers predictable in vivo function

    Adoptive cell therapy (ACT) has the potential to reinstate T cell-mediated immunity and help combat infectious diseases as well as cancer.1,2 Although lenti- or retroviral systems are commonly exploited for TCR editing3-8, these conventional strategies lack control over the quantity and the site of …

    Growing evidence supporting the need for proper controls and careful genetic characterization of genetically engineered models

    Over the last decades, technological advancements – vis-à-vis genome-editing - have led to more refined approaches to perform allele-specific manipulations. Among these developments, we count programmable endonucleases (e.g. TALEN, ZFN, CRISPR/Cas9).1 These tools not only allow engineering the genom…
    Show more

    Cergentis Frequently Asked Questions

    • When was Cergentis founded?

      Cergentis was founded in 2012.

    • Who are Cergentis key executives?

      Cergentis's key executives are Joris Schuurmans, Jan Dekker and Jan Groen.

    • How many employees does Cergentis have?

      Cergentis has 38 employees.

    • Who are Cergentis competitors?

      Competitors of Cergentis include Microbiome Insights, Mikrogen and Complement Genomics.

    • Where is Cergentis headquarters?

      Cergentis headquarters is located at Alexander Numangebouw, Yalelaan 62, Utrecht.

    • Where are Cergentis offices?

      Cergentis has an office in Utrecht.

    • How many offices does Cergentis have?

      Cergentis has 1 office.